Replies to post #406443 on Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

Caddie; Check this out... Clinical study performed on 34,647 patients using either (two arms) Methotrexate (anti-cancer drug) or Anti-TNF (anti-inflammatory drugs, such as Humira)

https://clinicaltrials.gov/ct2/show/NCT04571697?term=dementia&cond=Alzheimer+Disease&draw=2&rank=4

It's downright scary to think that people are being given a dangerous drug like Methotrexate to test the efficacy on Alzheimers patients. Humira I can understand. Are they grasping at straws or what?

Methotrexate
https://medlineplus.gov/druginfo/meds/a682019.html

Don't misunderstand me; I don't doubt that the BRAVE data will show some improvements in reducing Beta-amyloid Plaques. EPA has been shown to reduce Plaques correct? Thereby reducing the chances for a CV event.
https://lundquist.org/news/omega-3-drug-vascepa-slows-progress-heart-disease-new-study-lundquist-institute-hows#:~:text=Data%20from%20the%20study%20showed,particular%20type%20of%20heart%20disease.

I would venture an educated theory that Vascepa will reduce these Beta-amyloid plaques and reduce inflammation in the brain in the 65 individuals. My only concern is the BRAVE Study will not receive the attention it deserves when it proves successful. As it is apparent from Reduce-It stats, the medical community is still not convinced of Vascepa's efficacy. It's always about money, money, money!!! There was a ton of money spent on Reduce-It. IDK, maybe BRAVE will get some attention? If it "Pops" the stock price then I'm all for it.